75 related articles for article (PubMed ID: 23601248)
1. Discovery of a new bioactive molecule for neuroblastoma.
Leitão A; Schramm A; Eggert A
Chem Biol Drug Des; 2013 Aug; 82(2):233-41. PubMed ID: 23601248
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and biological role of neurotrophin-receptor TrkA and TrkB in neuroblastoma.
Eggert A; Ikegaki N; Liu XG; Brodeur GM
Klin Padiatr; 2000; 212(4):200-5. PubMed ID: 10994551
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of insulin-like growth factor I receptor activity by NVP-AEW541 has an antitumor effect on neuroblastoma cells in vitro and in vivo.
Tanno B; Mancini C; Vitali R; Mancuso M; McDowell HP; Dominici C; Raschellà G
Clin Cancer Res; 2006 Nov; 12(22):6772-80. PubMed ID: 17121898
[TBL] [Abstract][Full Text] [Related]
4. Microarray analysis reveals differential gene expression patterns and regulation of single target genes contributing to the opposing phenotype of TrkA- and TrkB-expressing neuroblastomas.
Schulte JH; Schramm A; Klein-Hitpass L; Klenk M; Wessels H; Hauffa BP; Eils J; Eils R; Brodeur GM; Schweigerer L; Havers W; Eggert A
Oncogene; 2005 Jan; 24(1):165-77. PubMed ID: 15637590
[TBL] [Abstract][Full Text] [Related]
5. Library construction and biological evaluation of enmein-type diterpenoid analogues as potential anticancer agents.
Li D; Xu S; Cai H; Pei L; Wang L; Wu X; Yao H; Jiang J; Sun Y; Xu J
ChemMedChem; 2013 May; 8(5):812-8. PubMed ID: 23520191
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor-II expression is down-regulated in TrkA-transfected SK-N-AS neuroblastoma cells.
Kim CJ; Chi JG; Thiele CJ
Lab Invest; 1999 Aug; 79(8):1007-13. PubMed ID: 10462038
[TBL] [Abstract][Full Text] [Related]
7. Discovery of a small molecular compound simultaneously targeting RXR and HADC: design, synthesis, molecular docking and bioassay.
Chen GL; Wang LH; Wang J; Chen K; Zhao M; Sun ZZ; Wang S; Zheng HL; Yang JY; Wu CF
Bioorg Med Chem Lett; 2013 Jul; 23(13):3891-5. PubMed ID: 23707260
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo antitumor activity of the novel derivatized polyvinyl alcohol-based polymer P10(4).
Raffaghello L; Zuccari G; Carosio R; Orienti I; Montaldo PG
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3485-93. PubMed ID: 16740774
[TBL] [Abstract][Full Text] [Related]
9. Morphobase, an encyclopedic cell morphology database, and its use for drug target identification.
Futamura Y; Kawatani M; Kazami S; Tanaka K; Muroi M; Shimizu T; Tomita K; Watanabe N; Osada H
Chem Biol; 2012 Dec; 19(12):1620-30. PubMed ID: 23261605
[TBL] [Abstract][Full Text] [Related]
10. Biological effects of TrkA and TrkB receptor signaling in neuroblastoma.
Schramm A; Schulte JH; Astrahantseff K; Apostolov O; Limpt Vv; Sieverts H; Kuhfittig-Kulle S; Pfeiffer P; Versteeg R; Eggert A
Cancer Lett; 2005 Oct; 228(1-2):143-53. PubMed ID: 15921851
[TBL] [Abstract][Full Text] [Related]
11. Artificially accumulated beta-catenin inhibits proliferation and induces neurite extension of neuroblastoma cell line NB-1 via up-regulation of trkA.
Sangkhathat S; Nara K; Kusafuka T; Yoneda A; Fukuzawa M
Oncol Rep; 2006 Dec; 16(6):1197-203. PubMed ID: 17089037
[TBL] [Abstract][Full Text] [Related]
12. The selective Trk inhibitor AZ623 inhibits brain-derived neurotrophic factor-mediated neuroblastoma cell proliferation and signaling and is synergistic with topotecan.
Zage PE; Graham TC; Zeng L; Fang W; Pien C; Thress K; Omer C; Brown JL; Zweidler-McKay PA
Cancer; 2011 Mar; 117(6):1321-91. PubMed ID: 20960503
[TBL] [Abstract][Full Text] [Related]
13. The novel atypical retinoid ST1926 is active in ATRA resistant neuroblastoma cells acting by a different mechanism.
Di Francesco AM; Meco D; Torella AR; Barone G; D'Incalci M; Pisano C; Carminati P; Riccardi R
Biochem Pharmacol; 2007 Mar; 73(5):643-55. PubMed ID: 17150196
[TBL] [Abstract][Full Text] [Related]
14. Effect of bortezomib on human neuroblastoma cell growth, apoptosis, and angiogenesis.
Brignole C; Marimpietri D; Pastorino F; Nico B; Di Paolo D; Cioni M; Piccardi F; Cilli M; Pezzolo A; Corrias MV; Pistoia V; Ribatti D; Pagnan G; Ponzoni M
J Natl Cancer Inst; 2006 Aug; 98(16):1142-57. PubMed ID: 16912267
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel small compounds that restore E-cadherin expression and inhibit tumor cell motility and invasiveness.
Hirano T; Satow R; Kato A; Tamura M; Murayama Y; Saya H; Kojima H; Nagano T; Okabe T; Fukami K
Biochem Pharmacol; 2013 Nov; 86(10):1419-29. PubMed ID: 24035834
[TBL] [Abstract][Full Text] [Related]
16. Aiming at neuroblastoma and hitting other worthy targets.
Schor NF
J Child Neurol; 2013 Jun; 28(6):768-73. PubMed ID: 23576410
[TBL] [Abstract][Full Text] [Related]
17. Discovering novel P38α inhibitors for the treatment of prostate cancer through virtual screening methods.
Li K; Li Z; Tao Y; Wang Q; Lai Y; Wu W; Peng S; Guo Z; Huang H
Future Med Chem; 2019 Dec; 11(24):3125-3137. PubMed ID: 31838901
[No Abstract] [Full Text] [Related]
18. Synthesis of methoxy- and bromo-substituted indirubins and their activities on apoptosis induction in human neuroblastoma cells.
Saito H; Tabata K; Hanada S; Kanda Y; Suzuki T; Miyairi S
Bioorg Med Chem Lett; 2011 Sep; 21(18):5370-3. PubMed ID: 21802947
[TBL] [Abstract][Full Text] [Related]
19. Effect of CEP-751 (KT-6587) on neuroblastoma xenografts expressing TrkB.
Evans AE; Kisselbach KD; Liu X; Eggert A; Ikegaki N; Camoratto AM; Dionne C; Brodeur GM
Med Pediatr Oncol; 2001 Jan; 36(1):181-4. PubMed ID: 11464878
[TBL] [Abstract][Full Text] [Related]
20. Oxidative stress modulates tyrosine kinase receptor A and p75 receptor (low-affinity nerve growth factor receptor) expression in SHSY5Y neuroblastoma cells.
Olivieri G; Otten U; Meier F; Baysang G; Dimitriades-Schmutz B; Müller-Spahn F; Savaskan E
Neurol Clin Neurophysiol; 2002; 2002(2):2-10. PubMed ID: 12028822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
